The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived-Reference-Cited by-同舟云学术

The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived

Published:2023-10-03 Issue:14 Volume:148 Page:1071-1073
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Ridker Paul M¹^ORCID

Affiliation:

1. Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

2. Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease

3. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome

4. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials

5. Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic association with autoimmune diseases identifies molecular mechanisms of coronary artery disease;iScience;2024-09

2. The Prognostic Value of Advanced Lung Cancer Inflammation Index in Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention;International Heart Journal;2024-07-31

3. Colchicine for the treatment of the spectrum of cardiovascular diseases: current evidence and ongoing perspectives;Journal of Cardiovascular Medicine;2024-07-19

4. Effect on C‐reactive protein levels of the addition of ezetimibe, bempedoic acid, or colchicine to statin treatment: A network meta‐analysis;Journal of Internal Medicine;2024-07-11

5. Current research status and future prospects of NLRP3 inflammasome in cardiovascular diseases: a bibliometric and visualization analysis;Frontiers in Cardiovascular Medicine;2024-07-03